XML 73 R62.htm IDEA: XBRL DOCUMENT v3.25.1
Convertible Promissory Notes and Notes Payable (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 07, 2025
Jul. 08, 2024
Feb. 10, 2025
Feb. 22, 2023
Oct. 19, 2022
Jun. 30, 2022
Mar. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Jan. 18, 2024
Additional warrants shares issued 116,668                  
Market price of issuance shares $ 2.74                  
Unamortized debt discount                 $ 213,813  
Expected volatility             253.00%      
Risk-free interest rate             3.99%      
Expected term             2 years      
Intrinsic values of debt discount             $ 107,262 $ 115,865    
Common stock per share                   $ 19.94
Interest rate           8.50%        
Investor [Member]                    
Description of amendment to the promissory note The term of the note is two (2) years and has an interest rate of three (3) percent. There are no interest or principal payments due during the term of the note. All principal and interest not converted during the term of the note is payable on March 7, 2027                  
Original principal amount $ 350,000                  
Common stock per share $ 3.00                  
Convertible Notes, 36-Month Term Notes [Member]                    
Sales of building   $ 4,300,000                
Proceeds from notes         $ 2,780,200          
Description of agreement         The Company received a forbearance agreement from the bank until June 30, 2024 to return to compliance of the debt service ratio of 1.25 to 1, until that time the Company will pay an interest rate of 10% instead of the contractual terms of 4.8%          
Holdback amount         $ 3,000,000          
Allan Marshall [Member]                    
Description of amendment to the promissory note           the Company executed an amendment to the promissory note with Mr. Marshall, providing for the payment of interest only for 18 months at an interest rate of 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025        
Common stock per share           $ 22.00        
Promissory notes Principal amount           $ 1,500,000        
Principal outstanding amount           $ 500,000        
Common stock share purchase           18,750        
Interest rate           8.50%        
Interest rate pik           3.50%        
VitaMedica Note [Member]                    
Total convertible common stock       $ 100,000   $ 1,000,000        
Promissory note Feb 22, 2023 Two [Member]                    
Common stock per share     $ 2.28              
Promissory notes Principal amount     $ 650,000              
Converted shares     285,000              
Promissory note Feb 22, 2023 One [Member]                    
Description of amendment to the promissory note       2-month period, starting in June of 2025            
Common stock per share       $ 22.00            
Promissory notes Principal amount       $ 2,150,000            
Principal outstanding amount       $ 2,150,000            
Common stock share purchase       25,000            
Promissory note Feb 22, 2023 [Member]                    
Description of amendment to the promissory note       the Company executed an amendment to the promissory note with the investor, providing for the payment of interest only for 18 months at 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025            
Common stock per share       $ 22.00            
Promissory notes Principal amount       $ 560,000            
Principal outstanding amount       $ 560,000            
Common stock share purchase       6,250